|  Help  |  About  |  Contact Us

Publication : Leukotriene B4 Enhances NOD2-Dependent Innate Response against Influenza Virus Infection.

First Author  Le Bel M Year  2015
Journal  PLoS One Volume  10
Issue  10 Pages  e0139856
PubMed ID  26444420 Mgi Jnum  J:243521
Mgi Id  MGI:5908773 Doi  10.1371/journal.pone.0139856
Citation  Le Bel M, et al. (2015) Leukotriene B4 Enhances NOD2-Dependent Innate Response against Influenza Virus Infection. PLoS One 10(10):e0139856
abstractText  Leukotriene B4 (LTB4), a central mediator of inflammation, is well known for its chemoattractant properties on effectors cells of the immune system. LTB4 also has the ability to control microbial infection by improving host innate defenses through the release of antimicrobial peptides and modulation of intracellular Toll-like receptors (TLRs) expression in response to agonist challenge. In this report, we provide evidences that LTB4 acts on nucleotide-binging oligomerization domain 2 (NOD2) pathway to enhance immune response against influenza A infection. Infected mice receiving LTB4 show improved survival, lung architecture and reduced lung viral loads as compared to placebo-treated animals. NOD2 and its downstream adaptor protein IPS-1 have been found to be essential for LTB4-mediated effects against IAV infection, as absence of NOD2 or IPS-1 diminished its capacity to control viral infection. Treatment of IAV-infected mice with LTB4 induces an increased activation of IPS-1-IRF3 axis leading to an enhanced production of IFNbeta in lungs of infected mice. LTB4 also has the ability to act on the RICK-NF-kappaB axis since administration of LTB4 to mice challenged with MDP markedly increases the secretion of IL-6 and TNFalpha in lungs of mice. TAK1 appears to be essential to the action of LTB4 on NOD2 pathway since pretreatment of MEFs with TAK1 inhibitor prior stimulation with IAV or MDP strongly abrogated the potentiating effects of LTB4 on both IFNbeta and cytokine secretion. Together, our results demonstrate that LTB4, through its ability to activate TAK1, potentiates both IPS-1 and RICK axis of the NOD2 pathway to improve host innate responses.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

2 Authors

4 Bio Entities

Trail: Publication

0 Expression